4//SEC Filing
Sorensen Mel 4
Accession 0000899243-21-013913
CIK 0001563577other
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 4:42 PM ET
Size
10.5 KB
Accession
0000899243-21-013913
Insider Transaction Report
Form 4
Sorensen Mel
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2021-03-26$1.14/sh+46,940$53,512→ 232,044 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-03-26−46,940→ 0 totalExercise: $1.14Exp: 2024-09-16→ Common Stock (46,940 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-03-26−170,075→ 0 totalExercise: $1.07Exp: 2022-11-25→ Common Stock (170,075 underlying) - Exercise/Conversion
Common Stock
2021-03-26$1.07/sh+170,075$181,980→ 185,104 total
Footnotes (1)
- [F1]The option has fully vested and is currently exercisable.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
Related Parties
1- filerCIK 0001444783
Filing Metadata
- Form type
- 4
- Filed
- Mar 29, 8:00 PM ET
- Accepted
- Mar 30, 4:42 PM ET
- Size
- 10.5 KB